as on October 15, 2025 at 10:38 pm IST
Day's Low
Day's High
1.45%
Downside
4.35%
Upside
52 Week's Low
52 Week's High
40.42%
Downside
360.72%
Upside
Check Sangamo Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$207.2M
EPS (TTM)
-0.4067
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.69
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
-58.3M
Revenue (TTM)
81.7M
Profit Margin
-77.48%
Return On Equity TTM
1851400.00%
Track how Sangamo Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Sangamo Therapeutics, Inc. in the last 5 years
Lowest (-12.09x)
June 30, 2021
Today (-0.69x)
October 15, 2025
Industry (-0.32x)
October 15, 2025
Highest (-0.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -0.69x
Compare market cap, revenue, PE, and other key metrics of Sangamo Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $207.2M | NA | -0.69 | -77.48% | |
BUY | $60.9B | 226.08% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $104.4B | 91.48% | 28.99 | 31.86% | |
BUY | $59.1B | -2.15% | 14.07 | 31.37% |
The Sangamo Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sangamo Therapeutics, Inc. investment value today
Current value as on today
₹75,965
Returns
Returns from Sangamo Therapeutics, Inc. Stock
Dollar Returns*
₹4,831 (+4.83%)
Based on 15 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Sangamo Therapeutics, Inc.. Average target price of $4.1
Get share price movements and forecasts by analysts on Sangamo Therapeutics, Inc..
What analysts predicted
83.17%UPSIDE
Target Price
$4.1
Current Price
$0.69
Analyzed by
15 Analysts
Target
$4.10
Sangamo Therapeutics, Inc. target price $4.1, a slight upside of 83.17% compared to current price of $0.69. According to 15 analysts rating.
Search interest for Sangamo Therapeutics, Inc. Stock has increased by 359% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:359% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -30.59M → -19.98M (in $), with an average increase of 53.1% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 6.43M → 18.30M (in $), with an average increase of 64.8% per quarter
Price Rise
In the last 1 month, SGMO stock has moved up by 37.2%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 92.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 238.2%
Organisation | Sangamo Therapeutics, Inc. |
Headquarters | 501 Canal Blvd, Richmond, CA, United States, 94804 |
Industry | Health Technology |
CEO | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Gregory Davis Ph.D. | Head of Research & Technology |
Mr. Scott B. Willoughby | Senior VP, Chief Legal Officer & Corporate Secretary |
Mr. Nikunj Jain | VP of Finance, Corporate Controller & Principal Accounting Officer |
Ms. Louise Wilkie | Head of Global Corporate Communications & Investor Relations |
Mr. Phillip Ramsey | Chief Technical Officer |
Ms. Stephanie J. Seiler CLP | VP and Head of Business Development & Alliance Management |
Mr. David Ojala | Scientist II - Discovery & Translational Research |
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. | CEO, President & Director |
Dr. Nathalie Dubois-Stringfellow Ph.D. | Senior VP & Chief Development Officer |
Sangamo Therapeutics, Inc. share price today is $0.69 as on . Sangamo Therapeutics, Inc. share today touched a day high of $0.72 and a low of $0.68.
Sangamo Therapeutics, Inc. share touched a 52 week high of $3.18 on and a 52 week low of $0.41 on . Sangamo Therapeutics, Inc. stock price today i.e. is trending at $0.69,which is 78.30% down from its 52 week high and 67.84% up from its 52 week low.
Sangamo Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Sangamo Therapeutics, Inc. (SGMO) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Sangamo Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sangamo Therapeutics, Inc. share’s latest price of $0.69 as on October 15, 2025 at 10:38 pm IST, you will get 14.4928 shares of Sangamo Therapeutics, Inc.. Learn more about
fractional shares .